Key result
Carotid-body tumors have a malignant potential of approximately 15%, complicating their management which historically carried a prohibitive operative mortality of 40% to 55%.
Answers are grounded in this paper and cite their sources.
Carotid-body tumors have a malignant potential of approximately 15%, complicating the historical debate between surgical extirpation and conservative management due to high past operative mortality.
Of all the neurogenous tumors occurring in the neck, the carotid-body tumor is the commonest and one of the most interesting. In the past five years considerable attention has been directed toward the diagnosis and treatment of this tumor. Disagreement and confusion have existed concerning the biology of this tumor and its management. Pathologists have disagreed about its malignant potentialities, and surgeons have disagreed as to whether the tumor should be extirpated or anoli-me-tangereattitude should be followed. Incontestable proof has been recently furnished that the carotid-body tumor manifests not only regional metastasis but can also spread throughout the body in a small percentage of cases. It is estimated that approximately 15% of the cases of carotid-body tumor are malignant, thus adding considerable gravity to their proper management.4Thenoli-me-tangereattitude was originally a consequence of the prohibitive operative mortality of 40%-55% reported in the past, when attempts
No takes yet. Share an insight, caveat, or question.
J. J. CONLEY (1956) conducted a review in Carotid-body tumor. Carotid-body tumors have a malignant potential of approximately 15%, complicating their management which historically carried a prohibitive operative mortality of 40% to 55%.
Synapse has enriched 10 related papers. Consider them for comparative context: